Jeffrey S. Parkin

Array ( [id] => 6242328 [patent_doc_number] => 20020045247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'METHODS FOR THE PREPARATION OF RETROVIRAL PARTICLES AND CELL LINES DEFICIENT IN THE ALPHA-GALACTOSYL EPITOPE' [patent_app_type] => new [patent_app_number] => 08/776161 [patent_app_country] => US [patent_app_date] => 1997-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20661 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045247.pdf [firstpage_image] =>[orig_patent_app_number] => 08776161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890626 [patent_doc_number] => 20010007857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'METHOD FOR TREATING FELINE IMMUNODEFIENCY VIRUS INFECTIONS' [patent_app_type] => new-utility [patent_app_number] => 08/835796 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2546 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007857.pdf [firstpage_image] =>[orig_patent_app_number] => 08835796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208396 [patent_doc_number] => 06713069 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Compositions and methods for detecting, preventing, and treating African Hemorrhagic Fever' [patent_app_type] => B1 [patent_app_number] => 08/838128 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11943 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713069.pdf [firstpage_image] =>[orig_patent_app_number] => 08838128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298007 [patent_doc_number] => 06197928 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Fluorescent protein sensors for detection of analytes' [patent_app_type] => 1 [patent_app_number] => 8/818252 [patent_app_country] => US [patent_app_date] => 1997-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 10 [patent_no_of_words] => 13984 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197928.pdf [firstpage_image] =>[orig_patent_app_number] => 818252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727422 [patent_doc_number] => 07041300 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-09 [patent_title] => 'Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines' [patent_app_type] => utility [patent_app_number] => 09/155003 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12049 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041300.pdf [firstpage_image] =>[orig_patent_app_number] => 09155003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640372 [patent_doc_number] => 06395541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I' [patent_app_type] => B1 [patent_app_number] => 08/814866 [patent_app_country] => US [patent_app_date] => 1997-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 17253 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395541.pdf [firstpage_image] =>[orig_patent_app_number] => 08814866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645765 [patent_doc_number] => 06472204 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Methods for retroviral mediated gene transfer employing molecules, or mixtures thereof, containing retroviral binding domains and target cell binding domains' [patent_app_type] => B1 [patent_app_number] => 08/809156 [patent_app_country] => US [patent_app_date] => 1997-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 38247 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472204.pdf [firstpage_image] =>[orig_patent_app_number] => 08809156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324274 [patent_doc_number] => 06331616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3' [patent_app_type] => 1 [patent_app_number] => 8/811682 [patent_app_country] => US [patent_app_date] => 1997-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 25632 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331616.pdf [firstpage_image] =>[orig_patent_app_number] => 811682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871313 [patent_doc_number] => 05837837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Nucleic acids molecules encoding Caspase-8h and Caspase-8i' [patent_app_type] => 1 [patent_app_number] => 8/807200 [patent_app_country] => US [patent_app_date] => 1997-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 18215 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837837.pdf [firstpage_image] =>[orig_patent_app_number] => 807200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1400909 [patent_doc_number] => 06531572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Metal chelate-labelled peptides' [patent_app_type] => B1 [patent_app_number] => 08/776189 [patent_app_country] => US [patent_app_date] => 1997-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6946 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531572.pdf [firstpage_image] =>[orig_patent_app_number] => 08776189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890623 [patent_doc_number] => 20010007854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'AN IN VITRO ASSAY METHOD FOR THE STUDY OF BRAIN AGING' [patent_app_type] => new-utility [patent_app_number] => 08/787784 [patent_app_country] => US [patent_app_date] => 1997-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7134 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007854.pdf [firstpage_image] =>[orig_patent_app_number] => 08787784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880442 [patent_doc_number] => 05798206 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptor' [patent_app_type] => 1 [patent_app_number] => 8/782044 [patent_app_country] => US [patent_app_date] => 1997-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3307 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798206.pdf [firstpage_image] =>[orig_patent_app_number] => 782044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290952 [patent_doc_number] => 06180389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules' [patent_app_type] => 1 [patent_app_number] => 8/775366 [patent_app_country] => US [patent_app_date] => 1997-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4987 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180389.pdf [firstpage_image] =>[orig_patent_app_number] => 775366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941260 [patent_doc_number] => 05976786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Screening methods for the identification of compounds that modulate apoptosis in immunodeficiency virus infected cells' [patent_app_type] => 1 [patent_app_number] => 8/774269 [patent_app_country] => US [patent_app_date] => 1996-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8687 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976786.pdf [firstpage_image] =>[orig_patent_app_number] => 774269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459397 [patent_doc_number] => 06426412 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-30 [patent_title] => 'Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements' [patent_app_type] => B1 [patent_app_number] => 08/775703 [patent_app_country] => US [patent_app_date] => 1996-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 8445 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426412.pdf [firstpage_image] =>[orig_patent_app_number] => 08775703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105064 [patent_doc_number] => 06022683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Methods for assessing the prognosis of a patient with a neurodegenerative disease' [patent_app_type] => 1 [patent_app_number] => 8/766975 [patent_app_country] => US [patent_app_date] => 1996-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 11 [patent_no_of_words] => 9554 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022683.pdf [firstpage_image] =>[orig_patent_app_number] => 766975 [rel_patent_id] =>[rel_patent_doc_number] =>)